iCELL Biotechnology 
Welcome,         Profile    Billing    Logout  
  Products    Diseases   Products    Trials    News 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
human amniotic epithelial stem cells (hAESCs) / iCELL Biotechnology
NCT04414813: Stereotactic Transplantation of hAESCs for Parkinson's Disease

Completed
1
3
RoW
Human Amniotic Epithelial Stem Cells
Shanghai East Hospital, Shanghai iCELL Biotechnology Co., Ltd, Shanghai, China
Parkinson's Disease
02/23
02/23
NCT05435755: Precise Transplantation of hAESCs Into the Ventricle for Parkinson's Disease.

Not yet recruiting
1
12
RoW
hAESCs treatment, placebo (saline)
Shanghai East Hospital, Shanghai iCELL Biotechnology Co., Ltd, Shanghai, China
Parkinson's Disease
07/23
08/23
NCT05691114: Precise Transplantation of Human Amniotic Epithelial Stem Cells Into Lateral Ventricle for Parkinson's Disease

Recruiting
1
18
RoW
hAESCs
Shanghai East Hospital, Shanghai iCELL Biotechnology Co., Ltd, Shanghai, China
Idiopathic Parkinson's Disease
02/25
02/26
ChiCTR2000033895: Clinical Study of Stereotactic Transplantation of Human Amniotic Epithelial Cells in the Treatment of Parkinson's Disease

Not yet recruiting
N/A
3
 
human amniotic epithelial stem cells stereotactic transplantation
Shanghai East Hospital; Level of the institution：, Shanghai iCELL Biotechnology Co., Ltd
Parkinson's disease
 
 
CD8+NKG2D+ AKT cell immunotherapy / iCELL Biotechnology
ChiCTR-INR-15007480: A Randomized, Double Blinding, Plancebo-Controlled Clinical Trials of CD8+NKG2D+ AKT cell immunotherapy to the panreatic cancer patients treated with adjuvant chemotherapy

Recruiting
N/A
72
 
surgical resection+Gemcitabine+placebo ;surgical resection+Gemcitabine+AKT cell
Shanghai First Peoples' Hospital; Shanghai First Peoples' Hospital, Shanghai First Peoples' Hospital; Icell Biotechnology Co., Ltd, Shanghai
pancreatic ductal adenocarcinoma
 
 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
human amniotic epithelial stem cells (hAESCs) / iCELL Biotechnology
NCT04414813: Stereotactic Transplantation of hAESCs for Parkinson's Disease

Completed
1
3
RoW
Human Amniotic Epithelial Stem Cells
Shanghai East Hospital, Shanghai iCELL Biotechnology Co., Ltd, Shanghai, China
Parkinson's Disease
02/23
02/23
NCT05435755: Precise Transplantation of hAESCs Into the Ventricle for Parkinson's Disease.

Not yet recruiting
1
12
RoW
hAESCs treatment, placebo (saline)
Shanghai East Hospital, Shanghai iCELL Biotechnology Co., Ltd, Shanghai, China
Parkinson's Disease
07/23
08/23
NCT05691114: Precise Transplantation of Human Amniotic Epithelial Stem Cells Into Lateral Ventricle for Parkinson's Disease

Recruiting
1
18
RoW
hAESCs
Shanghai East Hospital, Shanghai iCELL Biotechnology Co., Ltd, Shanghai, China
Idiopathic Parkinson's Disease
02/25
02/26
ChiCTR2000033895: Clinical Study of Stereotactic Transplantation of Human Amniotic Epithelial Cells in the Treatment of Parkinson's Disease

Not yet recruiting
N/A
3
 
human amniotic epithelial stem cells stereotactic transplantation
Shanghai East Hospital; Level of the institution：, Shanghai iCELL Biotechnology Co., Ltd
Parkinson's disease
 
 
CD8+NKG2D+ AKT cell immunotherapy / iCELL Biotechnology
ChiCTR-INR-15007480: A Randomized, Double Blinding, Plancebo-Controlled Clinical Trials of CD8+NKG2D+ AKT cell immunotherapy to the panreatic cancer patients treated with adjuvant chemotherapy

Recruiting
N/A
72
 
surgical resection+Gemcitabine+placebo ;surgical resection+Gemcitabine+AKT cell
Shanghai First Peoples' Hospital; Shanghai First Peoples' Hospital, Shanghai First Peoples' Hospital; Icell Biotechnology Co., Ltd, Shanghai
pancreatic ductal adenocarcinoma
 
 

Download Options